$321.61+26.61% · 3M
Moving avg
1W+0.76%
1M+18.24%
3M+28.44%
6M+13.79%
YTD+27.80%
1Y+18.57%
3Y+47.53%
5Y+22.22%
52-week range
$244.52100% of range$298.58
Company health
Value4/6
Growth2/6
Profitability3/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (1091%)
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$26.37B
Enterprise value
$30.59B
P/E ratio (TTM)
26.10x
P/S ratio (TTM)
1.72x
EV/EBITDA
14.83x
Per share & returns
EPS (TTM)
$11.44
Dividend yield
0.97%
Beta (1Y)
0.86
30-day change
+18.24%
Trading
Volume (24h)
92.84K
Previous close
$323.48
Shares outstanding
82.00M
About Labcorp Holdings Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Symbol
LH
Labcorp Holdings Inc. is a large-cap healthcare company in the Medical - Diagnostics & Research industry. Its shares are listed on NYSE (United States) and trade under the ticker LH.
Frequently asked questions
What is Labcorp Holdings Inc.'s market cap?
Labcorp Holdings Inc. (LH) has a market capitalization of $26.37B.
What is Labcorp Holdings Inc.'s P/E ratio?
Labcorp Holdings Inc. trades at a price-to-earnings (P/E) ratio of 26.10.
What exchange does LH trade on?
LH trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap